Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bolger

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Pharmaceutical Research|October 1, 1996
In vitro and in vivo activity of 16,17-dehydro-epipregnanolones: 17,20-bond torsional energy analysis and D-ring conformationM B Bolger, S Wieland, J E Hawkinson, et al.
Psychopharmacology|March 25, 1999
In vivo and in vitro hyperbaric studies in mice suggest novel sites of action for ethanolD L Davies, M B Bolger, R D Brinton, et al.
Journal of Clinical Pharmacology|February 1, 1979
The overdosage and/or poisoning information gapP B Bolger, S K Shimomura, G C Cupit, et al.
BMC Biochemistry|August 24, 2002
Delineation of RAID1, the RACK1 interaction domain located within the unique N-terminal region of the cAMP-specific phosphodiesterase, PDE4D5Graeme B Bolger, Angela McCahill, Stephen J Yarwood, et al.
Gynecologic Oncology|March 1, 1997
E-cadherin and integrin cell adhesion molecule expression in invasive and in situ carcinoma of the cervixM D Jeffers, J Paxton, B Bolger, et al.
The Journal of Biological Chemistry|April 1, 2000
UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactionsM B Beard, A E Olsen, R E Jones, et al.
European Journal of Pharmacology|October 14, 1994
The neuroactive steroid 3 alpha-hydroxy-5 beta-pregnan-20-one is a two-component modulator of ligand binding to the GABAA receptorJ E Hawkinson, C L Kimbrough, L D McCauley, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-F442A preadipocytesS J MacKenzie, S J Yarwood, A H Peden, et al.
Pharmaceutical Research|May 15, 2020
Translational Modeling Strategies for Orally Administered Drug Products: Academic, Industrial and Regulatory PerspectivesSandra Suarez-Sharp, Anders Lindahl, Tycho Heimbach, et al.
The Journal of Biological Chemistry|September 23, 2003
The unique amino-terminal region of the PDE4D5 cAMP phosphodiesterase isoform confers preferential interaction with beta-arrestinsGraeme B Bolger, Angela McCahill, Elaine Huston, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Pharmaceutical Research|October 1, 1996
In vitro and in vivo activity of 16,17-dehydro-epipregnanolones: 17,20-bond torsional energy analysis and D-ring conformationM B Bolger, S Wieland, J E Hawkinson, et al.
Psychopharmacology|March 25, 1999
In vivo and in vitro hyperbaric studies in mice suggest novel sites of action for ethanolD L Davies, M B Bolger, R D Brinton, et al.
Journal of Clinical Pharmacology|February 1, 1979
The overdosage and/or poisoning information gapP B Bolger, S K Shimomura, G C Cupit, et al.
BMC Biochemistry|August 24, 2002
Delineation of RAID1, the RACK1 interaction domain located within the unique N-terminal region of the cAMP-specific phosphodiesterase, PDE4D5Graeme B Bolger, Angela McCahill, Stephen J Yarwood, et al.
Gynecologic Oncology|March 1, 1997
E-cadherin and integrin cell adhesion molecule expression in invasive and in situ carcinoma of the cervixM D Jeffers, J Paxton, B Bolger, et al.
The Journal of Biological Chemistry|April 1, 2000
UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactionsM B Beard, A E Olsen, R E Jones, et al.
European Journal of Pharmacology|October 14, 1994
The neuroactive steroid 3 alpha-hydroxy-5 beta-pregnan-20-one is a two-component modulator of ligand binding to the GABAA receptorJ E Hawkinson, C L Kimbrough, L D McCauley, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1998
Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-F442A preadipocytesS J MacKenzie, S J Yarwood, A H Peden, et al.
Pharmaceutical Research|May 15, 2020
Translational Modeling Strategies for Orally Administered Drug Products: Academic, Industrial and Regulatory PerspectivesSandra Suarez-Sharp, Anders Lindahl, Tycho Heimbach, et al.
The Journal of Biological Chemistry|September 23, 2003
The unique amino-terminal region of the PDE4D5 cAMP phosphodiesterase isoform confers preferential interaction with beta-arrestinsGraeme B Bolger, Angela McCahill, Elaine Huston, et al.
Pageof 14